PHARMACOLOGICAL NEUROPROTECTION IN ISCHEMIC BRAIN LESIONS (PART 4. JUSTIFICATION OF THE CHOICE AND PHARMACODYNAMICS OF AGENTS FOR ACTIVATING ENDOGENOUS NEUROPROTECTION MECHANISMS) - PDF (Russian)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
